Trial Profile
A Randomized, Multicenter, Open-label, 6-month Study to Explore the Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Mycophenolate sodium (Primary) ; Methylprednisolone; Prednisone
- Indications Lupus nephritis
- Focus Therapeutic Use
- Sponsors Novartis
- 03 Sep 2014 New trial record